Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandplejerklinikken v / HelleTranberg Nielsen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.7% 3.1% 2.9% 2.7% 3.3% 2.6% 19.1% 19.1%   Credit score (0-100)   61 58 58 59 55 60 7 7   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   731 488 484 468 500 564 0.0 0.0   EBITDA   345 181 82.0 54.0 17.0 40.0 0.0 0.0   EBIT   240 72.0 18.0 40.0 8.0 27.3 0.0 0.0   Pre-tax profit (PTP)   206.0 59.0 10.0 34.0 8.0 27.4 0.0 0.0   Net earnings   160.0 45.0 7.0 24.0 5.0 18.9 0.0 0.0   Pre-tax profit without non-rec. items   206 59.0 10.0 34.0 8.0 27.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   14.0 30.0 55.0 40.0 30.0 14.1 0.0 0.0   Shareholders equity total   120 165 172 156 136 154 29.4 29.4   Interest-bearing liabilities   225 125 25.0 34.0 34.0 34.9 0.0 0.0   Balance sheet total (assets)   411 368 260 231 237 255 29.4 29.4   Net Debt   138 -5.0 -37.0 -32.0 -36.0 -70.5 -29.4 -29.4     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   731 488 484 468 500 564 0.0 0.0   Gross profit growth   10.4% -33.2% -0.8% -3.3% 6.8% 12.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   411 368 260 231 237 255 29 29   Balance sheet change%   -11.8% -10.5% -29.3% -11.2% 2.6% 7.6% -88.5% 0.0%   Added value   345.0 181.0 82.0 54.0 22.0 40.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -211 -193 -89 -29 -19 -29 -14 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   32.8% 14.8% 3.7% 8.5% 1.6% 4.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   52.3% 18.5% 5.7% 16.3% 3.4% 11.1% 0.0% 0.0%   ROI %   59.7% 22.7% 7.4% 20.7% 4.2% 13.8% 0.0% 0.0%   ROE %   54.6% 31.6% 4.2% 14.6% 3.4% 13.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   29.2% 44.8% 66.2% 67.5% 57.4% 60.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   40.0% -2.8% -45.1% -59.3% -211.8% -176.2% 0.0% 0.0%   Gearing %   187.5% 75.8% 14.5% 21.8% 25.0% 22.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.9% 7.4% 10.7% 20.3% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.4 1.5 2.2 2.5 2.3 2.7 0.0 0.0   Current Ratio   1.5 1.6 2.3 2.5 2.5 2.9 0.0 0.0   Cash and cash equivalent   87.0 130.0 62.0 66.0 70.0 105.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   81.0 110.0 117.0 116.0 124.0 158.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   345 181 82 54 22 40 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   345 181 82 54 17 40 0 0   EBIT / employee   240 72 18 40 8 27 0 0   Net earnings / employee   160 45 7 24 5 19 0 0